Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Aspire Biopharma Holdings ( (ASBP) ) just unveiled an announcement.
On November 4, 2025, Aspire Biopharma Holdings‘ stockholders approved two significant proposals at a Special Meeting. The first proposal granted the board discretionary authority to amend the company’s certificate of incorporation to effect a reverse stock split of common stock within a one-year timeframe. The second proposal approved the issuance of more than 19.99% of outstanding shares upon exercise of Convertible Promissory Notes, adhering to Nasdaq rules, with a specified floor price for conversion.
More about Aspire Biopharma Holdings
Aspire Biopharma Holdings, Inc. operates in the biopharmaceutical industry, focusing on developing innovative therapies to address unmet medical needs.
Average Trading Volume: 22,293,824
Technical Sentiment Signal: Sell
Current Market Cap: $17.18M
For a thorough assessment of ASBP stock, go to TipRanks’ Stock Analysis page.